Research ArticleRheumatoid Arthritis
Patient Preferences for Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review
Caylib Durand, Maysoon Eldoma, Deborah A. Marshall, Nick Bansback and Glen S. Hazlewood
The Journal of Rheumatology February 2020, 47 (2) 176-187; DOI: https://doi.org/10.3899/jrheum.181165
Caylib Durand
From the Department of Medicine and Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Arthritis Research
Canada; Centre for Health Evaluation and Outcome Sciences, Providence Health Care, St. Paul’s Hospital, Vancouver, British Columbia,
Canada.
Maysoon Eldoma
Deborah A. Marshall
Nick Bansback
Glen S. Hazlewood
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 47, Issue 2
1 Feb 2020
Patient Preferences for Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review
Caylib Durand, Maysoon Eldoma, Deborah A. Marshall, Nick Bansback, Glen S. Hazlewood
The Journal of Rheumatology Feb 2020, 47 (2) 176-187; DOI: 10.3899/jrheum.181165